FDA Drug Recalls

Recalls / Class II

Class IID-0773-2017

Product

PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

Affected lot / code info
Lot # t11-21-2016@115, Exp 5/21/2017; t11-23-2016@109, Exp 5/27/2017; t12-13-2016@94, Exp 6/12/2017; t01-19-2017@85, Exp 7/22/2017; 02/01/2017@116, Exp 7/31/2017

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling firm

Firm
Key Pharmacy and Compounding Center
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
530 S 336th St, Federal Way, Washington 98003-6383

Distribution

Quantity
86 vials total (78/5mL vials and 8/50mL vials)
Distribution pattern
Distributed nationwide in U.S.A., Australia and Canada.

Timeline

Recall initiated
2017-04-18
FDA classified
2017-05-17
Posted by FDA
2017-05-24
Terminated
2017-08-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0773-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.